|
Age
|
|
< 60 years
|
21
|
1
| | |
1
| | |
|
≥ 60 years
|
6
|
1.58
|
0.957–2.164
|
0.086
|
1.97
|
1.180–2.668
|
0.059
|
|
Menstrual status
|
|
Premenopausal
|
9
| | | | | | |
|
Postmenopausal
|
18
|
1.792
|
1.057–2.601
|
0.034
|
1.32
|
0.847–1.809
|
0.072
|
|
Primary tumor size (cm)
|
|
< 2
|
15
|
1
| | |
1
| | |
|
2–5
|
6
|
1.675
|
1.011–2.917
|
0.045
|
1.115
|
0.980–3.028
|
0.021
|
|
≥ 5
|
5
|
2.174
|
1.039–4.632
|
0.037
|
2.538
|
1.157–4.251
|
0.001
|
|
Tumor involving chest wall
|
1
|
3.548
|
1.387–8.171
|
0.040
|
1.478
|
1.245–1.773
|
0.004
|
|
Number of axillary metastatic lymph nodes
|
|
0
|
14
|
1
| | |
1
| | |
|
1–3
|
8
|
1.726
|
0.962–2.928
|
0.049
|
1.971
|
1.939–3.752
|
0.041
|
|
≥ 4
|
5
|
2.279
|
1.062–3.373
|
0.001
|
1.960
|
1.017–3.758
|
0.037
|
|
ER/PR status
|
|
Positive
|
18
|
1
| | |
1
| | |
|
Negative
|
9
|
2.120
|
1.204–3.243
|
0.024
|
2.310
|
1.673–3.554
|
0.000
|
|
Her-2 status
|
|
Positive
|
15
|
1
| | |
1
| | |
|
Negative
|
12
|
1.490
|
1.245–1.783
|
0.01
|
1.971
|
1.193–3.255
|
0.150
|
|
Time to postoperative liver metastasis (months)
| |
1
| | |
1
| | |
|
24
|
16
| | | | | | |
|
≥ 24
|
11
|
1.971
|
1.073–3.578
|
0.028
|
0.561
|
0.327–0.965
|
0.037
|
|
Number of intrahepatic lesions (N)
|
|
Single
|
5
|
1
| | |
1
| | |
|
Multiple
|
22
|
1.630
|
1.074–3.383
|
0.056
|
1.67
|
1.243–2.255
|
0.079
|
|
Size of intrahepatic lesions (cm)
|
|
< 3
|
3
|
1
| | |
1
| | |
|
≥ 3
|
24
|
1.524
|
0.448–2.171
|
0.012
|
1.822
|
1.028–3.339
|
0.060
|
|
Presence of extrahepatic metastasis
|
|
Yes
|
16
|
1
| | |
1
| | |
|
No
|
11
|
1.578
|
1.012–3.654
|
0.001
|
0.258
|
0.214–1.012
|
0.593
|
|
Was combination therapy adopted?
|
|
Yes
|
18
|
1
| | |
1
| | |
|
No
|
9
|
2.275
|
1.462–3.540
|
0.000
|
0.891
|
0.799–0.993
|
0.037
|
